Director, NICE Scientific Advice
Brad is Director, NICE Scientific Advice working with companies and technology developers to develop good evidence for evaluation and to identify routes to patient access in the NHS. Prior to this he led the development of NICE’s managed access function which enables earlier patient access to medicines, while further real-world evidence generation addresses evidential uncertainty that might otherwise delay a commissioning decision. Working closely with NHS England, the Accelerated Access Collaborative and NHS data custodians Brad led the development of a data collection approach to support the delivery of date for the Cancer Drugs Fund and the Innovative Medicines Fund. He is also leading developments around the use of real-world evidence to support earlier adoption and spread of promising medical technologies. Prior to joining NICE, Brad worked for NHS England and understands commissioning approaches; and at Cancer Research UK where he led an international research partnership, giving insight in patient perspectives to innovation and use of real-world data to support decision-making.